• Publications
  • Influence
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on
Background—Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes inExpand
  • 1,308
  • 140
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on
Background. Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes inExpand
  • 1,277
  • 89
  • PDF
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
Background: Kawasaki disease is an acute vasculitis of childhood that leads to coronary artery aneurysms in ≈25% of untreated cases. It has been reported worldwide and is the leading cause ofExpand
  • 858
  • 69
  • PDF
Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee,
BACKGROUND The purpose of this statement is to update the recommendations by the American Heart Association (AHA) for the prevention of infective endocarditis that were last published in 1997. Expand
  • 1,177
  • 62
  • PDF
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
Background—Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes inExpand
  • 186
  • 25
  • PDF
Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee,
BACKGROUND The purpose of this statement is to update the recommendations by the American Heart Association (AHA) for the prevention of infective endocarditis, which were last published in 1997. Expand
  • 1,537
  • 19
  • PDF
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind,
BACKGROUND Phosphatidylinositol 3-kinase (PI3K) pathway activation is a hallmark of endocrine therapy-resistant, hormone receptor-positive breast cancer. This phase 3 study assessed the efficacy ofExpand
  • 274
  • 16
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
BACKGROUND Treatment of acute Kawasaki disease with intravenous immune globulin and aspirin reduces the risk of coronary-artery abnormalities and systemic inflammation, but despite intravenous immuneExpand
  • 299
  • 9
Special Report Diagnosis and Therapy of Kawasaki Disease in Children
Adnan S. Dajani, MD, Chairman; Kathryn A. Taubert, PhD; Michael A. Gerber, MD; Stanford T. Shulman, MD; Patricia Ferrieri, MD; Michael Freed, MD; Masato Takahashi, MD; Fredrick Z. Bierman, MD; AdolfExpand
  • 469
  • 8
Respiratory Epithelial Adenomatoid Hamartoma in the Nasal Cavity
We report a 65-year-old male with a hamartoma in the left nasal cavity. A mass was found in the left nasal cavity and was diagnosed as a benign tumor on the basis of preoperative findings. LeftExpand
  • 63
  • 8